Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis (NAVIGATE)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04365868 |
Recruitment Status :
Active, not recruiting
First Posted : April 28, 2020
Last Update Posted : November 9, 2023
|
Sponsor:
Galectin Therapeutics Inc.
Information provided by (Responsible Party):
Galectin Therapeutics Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Estimated Primary Completion Date : | December 2024 |
Estimated Study Completion Date : | December 2024 |